Browsing by Author Marc Lallemant

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 45 to 64 of 70 < previous   next >
Issue DateTitleAuthor(s)
1-Jan-2015New-onset diabetes and antiretroviral treatments in HIV-infected adults in ThailandPrakit Riyaten; Nicolas Salvadori; Patrinee Traisathit; Nicole Ngo-Giang-Huong; Tim R. Cressey; Prattana Leenasirimakul; Malee Techapornroong; Chureeratana Bowonwatanuwong; Pacharee Kantipong; Ampaipith Nilmanat; Naruepon Yutthakasemsunt; Apichat Chutanunta; Suchart Thongpaen; Virat Klinbuayaem; Luc Decker; Sophie Le Coeur; Marc Lallemant; Jacqueline Capeau; Jean Yves Mary; Gonzague Jourdain
15-Jun-2013Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: Programmatic implications for countries phasing out stavudineMichele W. Tang; Soo Yon Rhee; Silvia Bertagnolio; Nathan Ford; Susan Holmes; Kim C. Sigaloff; Raph L. Hamers; Tobias F.Rinke De Wit; Herve J. Fleury; Phyllis J. Kanki; Kiat Ruxrungtham; Claudia A. Hawkins; Carole L. Wallis; Wendy Stevens; Gert U. Van Zyl; Weerawat Manosuthi; Mina C. Hosseinipour; Nicole Ngo-Giang-Huong; Laurent Belec; Martine Peeters; Avelin Aghokeng; Torsak Bunupuradah; Sherri Burda; Patricia Cane; Giulia Cappelli; Charlotte Charpentier; Anoumou Y. Dagnra; Alaka K. Deshpande; Ziad El-Katib; Susan H. Eshleman; Joseph Fokam; Jean Chrysostome Gody; David Katzenstein; Donato D. Koyalta; Johnstone J. Kumwenda; Marc Lallemant; Lutgarde Lynen; Vincent C. Marconi; Nicolas A. Margot; Sandrine Moussa; Thumbi Ndung'U; Phillipe N. Nyambi; Catherine Orrell; Jonathan M. Schapiro; Rob Schuurman; Sunee Sirivichayakul; Davey Smith; Maria Zolfo; Michael R. Jordan; Robert W. Shafer
1-Jan-2017Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patientsNaïm Bouazza; Tim R. Cressey; Frantz Foissac; Andrzej Bienczak; Paolo Denti; Helen McIlleron; David Burger; Martina Penazzato; Marc Lallemant; Edmund V. Capparelli; Jean Marc Treluyer; Saïk Urien
15-Aug-2018Optimizing Clinical Trial Design to Maximize Evidence Generation in Pediatric HIVDeborah Ford; Rebecca Turner; Anna Turkova; Martina Penazzato; Victor Musiime; Mutsa Bwakura-Dangarembizi; Avy Violari; Chishala Chabala; Thanyawee Puthanakit; Tavitiya Sudjaritruk; Tim R. Cressey; Marc Lallemant; Diana M. Gibb
1-Sep-2021Outbreaks of covid-19 in nursing homes: A cross-sectional survey of 74 nursing homes in a french areaEmilie Piet; Alexis Maillard; Franck Olivier Mallaval; Jean Yves Dusseau; Murielle Galas-Haddad; Sébastien Ducki; Hélène Creton; Marc Lallemant; Emmanuel Forestier; Gaëtan Gavazzi; Tristan Delory
1-Jan-2022Pediatric COVID-19 Therapeutics: Seizing the Right Research and Development Opportunities to Accelerate Access for ChildrenSébastien Morin; Marc Lallemant; Anthony Garcia-Prats; Linda Lewis; Melynda Watkins; Carlo Giaquinto; Marie Valentin; Martina Penazzato; John C. Reeder
1-Jul-2020Perinatal Antiretroviral Intensification to Prevent Intrapartum HIV Transmission When Antenatal Antiretroviral Therapy Is Initiated Less Than 8 Weeks Before DeliveryMarc Lallemant; Billy Amzal; Patumrat Sripan; Saïk Urien; Tim R. Cressey; Nicole Ngo-Giang-Huong; Virat Klinbuayaem; Boonsong Rawangban; Prapan Sabsanong; Thitiporn Siriwachirachai; Tapnarong Jarupanich; Prateep Kanjanavikai; Phaiboon Wanasiri; Suporn Koetsawang; Gonzague Jourdain; Sophie Le Coeur
16-Mar-2009Perinatal zidovudine prophylaxis in HIV type-1-infected pregnant women with thalassaemia carriage in ThailandNelly Briand; Sakorn Pornprasert; Nicole Ngo-Giang-Huong; Fréderic Galactéros; Serge Pissara; Thanusak Tatu; Torpong Sanguansermsri; Gonzague Jourdoin; Marc Lallemant; Sophie Le Coeur
12-Jan-2010Pharmacogenetics and the prevention of mother-to-child transmission of HIVTim R. Cressey; Marc Lallemant
1-Mar-2022Pharmacokinetics and Safety of the Abacavir/Lamivudine/Lopinavir/Ritonavir Fixed-Dose Granule Formulation (4-in-1) in Neonates: PETITE StudyAdrie Bekker; Helena Rabie; Nicolas Salvadori; Samantha Du Toit; Kanchana Than-In-At; Marisa Groenewald; Isabelle Andrieux-Meyer; Mukesh Kumar; Ratchada Cressey; James Nielsen; Edmund Capparelli; Marc Lallemant; Mark F. Cotton; Tim R. Cressey
10-Sep-2010Pharmacokinetics and virologic response of zidovudine/lopinavir/ritonavir initiated during the third trimester of pregnancyTim R. Cressey; Gonzague Jourdain; Boonsong Rawangban; Supang Varadisai; Rucha Kongpanichkul; Prapan Sabsanong; Prapap Yuthavisuthi; Somnuk Chirayus; Nicole Ngo-Giang-Huong; Nipunporn Voramongkol; Somsak Pattarakulwanich; Marc Lallemant
15-May-2008Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected childrenTim R. Cressey; Hannah Green; Saye Khoo; Jean Marc Treluyer; Alexandra Compagnucci; Yacine Saidi; Marc Lallemant; Diana M. Gibb; David M. Burger
1-May-2012Predictors of 5-year mortality in HIV-infected adults starting highly active antiretroviral therapy in ThailandFederica Fregonese; Intira J. Collins; Gonzague Jourdain; Sophie LeCoeur; Tim R. Cressey; Nicole Ngo-Giang-Houng; Sukit Banchongkit; Apichat Chutanunta; Malee Techapornroong; Marc Lallemant
8-Nov-2016Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children - a EuroCoord-CHAIN-EPPICC joint projectNicole Ngo-Giang-Huong; Linda Wittkop; Ali Judd; Peter Reiss; Tessa Goetghebuer; Dan Duiculescu; Antoni Noguera-Julian; Magdalena Marczynska; Carlo Giacquinto; Luminita Ene; Jose T. Ramos; Cristina Cellerai; Thomas Klimkait; Benedicte Brichard; Niels Valerius; Caroline Sabin; Ramon Teira; Niels Obel; Christoph Stephan; Stéphane de Wit; Claire Thorne; Diana Gibb; Christine Schwimmer; Maria Athena Campbell; Deenan Pillay; Marc Lallemant; Vibeke Rosenfeldt; François Dabis
15-Jun-2013Prevalence, risk factors, and impact of isolated antibody to hepatitis B core antigen and occult hepatitis B virus infection in HIV-1-infected pregnant womenWoottichai Khamduang; Nicole Ngo-Giang-Huong; Catherine Gaudy-Graffin; Gonzague Jourdain; Weerapong Suwankornsakul; Tapnarong Jarupanich; Veeradate Chalermpolprapa; Sirisak Nanta; Noossara Puarattana-Aroonkorn; Sakchai Tonmat; Marc Lallemant; Alain Goudeau; Wasna Sirirungsi
1-Jan-2015Randomized noninferiority trial of two maternal single-dose nevirapine-sparing regimens to prevent perinatal HIV in ThailandMarc Lallemant; Sophie Le Coeur; Wasna Sirirungsi; Tim R. Cressey; Nicole Ngo-Giang-Huong; Patrinee Traisathit; Virat Klinbuayaem; Prapan Sabsanong; Prateep Kanjanavikai; Gonzague Jourdain; Kenneth McIntosh; Suporn Koetsawang
23-Nov-2011Resistance patterns selected by nevirapine vs. efavirenz in HIV-infected patients failing first-line antiretroviral treatment: A Bayesian analysisNicole Ngo-Giang-Huong; Gonzague Jourdain; Billy Amzal; Pensiriwan Sang-a-gad; Rittha Lertkoonalak; Naree Eiamsirikit; Somboon Tansuphasawasdikul; Yuwadee Buranawanitchakorn; Naruepon Yutthakasemsunt; Sripetcharat Mekviwattanawong; Kenneth McIntosh; Marc Lallemant
1-Dec-2007Risk factors for in utero or intrapartum mother-to-child transmission of human immunodeficiency virus type 1 in ThailandGonzague Jourdain; Jean Yves Mary; Sophie Le Coeur; Nicole Ngo-Giang-Huong; Praparb Yuthavisuthi; Aram Limtraku; Patrinee Traisathit; Kenneth McIntosh; Marc Lallemant
1-Apr-2009Risk factors of preterm delivery in HIV-infected pregnant women receiving zidovudine for the prevention of perinatal HIVPatrinee Traisathit; Jean Yves Mary; Sophie Le Cœur; Sudanee Thantanarat; Sivaporn Jungpichanvanich; Witaya Pornkitprasarn; Vorapin Gomutbutra; Wanmanee Matanasarawut; Wiroj Wannapira; Marc Lallemant
24-Sep-2020Risky injection practices and HCV awareness in Chiang Mai Province, Thailand: a respondent-driven sampling study of people who inject drugsMyrtille Prouté; Sophie Le Coeur; Métrey H. Tiv; Timothée Dub; Parinya Jongpaijitsakul; Anantika Ratnamhin; Chaisiri Angkurawaranon; Apinun Aramrattana; Marc Lallemant